Skip to main content
. 2021 Jan-Feb;66(1):67–73. doi: 10.4103/ijd.IJD_206_20

Table 2.

Changes in IL-1 between treatment arms

IL-1 PPD group (n=9) Mw group (n=11) MMR group (n=12) P (between groups)
Baseline 3.22±1.56 8.09±9.08 5.58±2.23 0.017
3 (2, 4.25) 6 (4.25, 7.5) 5.58 (4, 7)
End of treatment 6.78±4.21 9±8.81 25.75±59.41 0.830
5 (4.75, 7.5) 7 (3.5, 8) 5 (2.5, 19.5)
P (within groups) 0.008 0.465 0.432

P-value for between groups by Kruskal–Wallis ANOVA. • P-value for within groups by Wilcoxon test